About Aarti Pharmalabs Limited
Data last updated: 14 July 2026
Aarti Pharmalabs Limited is a public limited company based in Vapi, Gujarat, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 22 November 2019, the company has been in operation for over 7 years.
Registered with ROC Ahmedabad under CIN U24100GJ2019PLC110964. Listed on BSE: 543748.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹45.34 Cr. Formerly known as Aarti Organics Limited. It is led by directors including Vilas Gaikar Gajanan and Rupal Anand Vora.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 22/C/1 & 22/C/2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹1,819.44 Cr, a decline of 13.98% compared to the previous year. The net worth stands at ₹2,124.6 Cr (up 6.77% YoY). Total assets are valued at ₹3,481.71 Cr (up 19.79% YoY).
The company has a workforce of approximately 2,004 employees as per the latest available data.
The company is associated with 2 brands - Aarti Industries, Aarti Pharmalabs. As per MCA filings, the company has open charges of ₹791 Cr and satisfied charges of ₹75 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aartipharmalabs.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressPlot No. 22/C/1 & 22/C/2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited has one previous CIN (Corporate Identification Number): U24100GJ2019PLC110964. The current CIN is L24100GJ2019PLC110964, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100GJ2019PLC110964 | Current |
| U24100GJ2019PLC110964 | Previous |
Associated Brands with Aarti Pharmalabs Limited
Aarti Pharmalabs Limited operates two associated brands: Aarti Industries and Aarti Pharmalabs. These brands represent Aarti Pharmalabs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Specialty chemicals, pharmaceuticals, and surfactants are manufactured. | aarti-industries.com | |
| Active pharmaceutical ingredients and intermediates are manufactured by Aarti Pharmalabs. | aartipharmalabs.com |
Business Activity of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Aarti Pharmalabs Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is audited by Gokhale & Sathe Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Gokhale & Sathe Chartered Accountants (ICAI peer reviewed, certificate valid till 2027-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is currently managed by 12 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vilas Gaikar Gajanan | Director | 17 Oct 2022 | 3 Years 9 Months | Current |
|
Rupal Anand Vora
Also directs:
Runwal Developers Limited, Sanathan Textiles Limited, Geecee Ventures Limited and 5 more
|
Director | 17 Oct 2022 | 3 Years 9 Months | Current |
|
Parimal Hasmukhlal Desai
Also directs:
Pashima Enterprises Llp, Aarti Surfactants Limited, Valiant Organics Limited and 4 more
|
Director | 17 Oct 2022 | 3 Years 9 Months | Current |
|
Hetal Gogri Gala
Also directs:
Gogri Enterprises Limited Liability Partnership, Genesis Unichem Llp, Rose Peach Commercials Llp and 5 more
|
Managing Director | 07 Aug 2021 | 4 Years 11 Months | Current |
| Bhavesh Rasiklal Vora | Director | 17 Oct 2022 | 3 Years 9 Months | Current |
| Vinay Gopal Nayak | Director | 17 Oct 2022 | 3 Years 9 Months | Current |
Financials of Aarti Pharmalabs Limited FY 2026 filings available
Aarti Pharmalabs Limited reported revenue of ₹1,819.44 Cr (down 13.98% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹1,819.44 Cr | ₹2,115.07 Cr | ₹1,852.61 Cr | ₹1,945.23 Cr |
| Other Income | ₹9.75 Cr | ₹10.12 Cr | ₹4.9 Cr | ₹2.32 Cr |
| Total Income | ₹1,829.19 Cr | ₹2,125.19 Cr | ₹1,857.5 Cr | ₹1,947.55 Cr |
| Cost of Materials Consumed | ₹830.06 Cr | ₹887.02 Cr | ₹858.45 Cr | ₹1,014.3 Cr |
| Purchases of Stock-in-Trade | ₹55.95 Cr | ₹176.63 Cr | ₹182.22 Cr | ₹280.82 Cr |
| Changes in Inventories | -₹51.18 Cr | ₹64.22 Cr | -₹19.95 Cr | -₹125.36 Cr |
| Employee Benefit Expense | ₹173.09 Cr | ₹161.96 Cr | ₹138.41 Cr | ₹129.69 Cr |
| Finance Costs | ₹46.9 Cr | ₹26.9 Cr | ₹17.21 Cr | ₹21.05 Cr |
| Depreciation & Amortisation | ₹104.34 Cr | ₹86.9 Cr | ₹73.24 Cr | ₹62.54 Cr |
| Other Expenses | ₹442.31 Cr | ₹360.87 Cr | ₹307.44 Cr | ₹303.74 Cr |
| Total Expenses | ₹1,601.47 Cr | ₹1,764.5 Cr | ₹1,557.01 Cr | ₹1,686.78 Cr |
| Profit Before Exceptional Items & Tax | ₹227.72 Cr | ₹360.69 Cr | ₹300.49 Cr | ₹260.77 Cr |
| Exceptional Items | -₹2.79 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹224.92 Cr | ₹360.69 Cr | ₹300.49 Cr | ₹260.77 Cr |
| Total Tax Expense | ₹58.21 Cr | ₹88.28 Cr | ₹83.59 Cr | ₹67.28 Cr |
| Net Profit | ₹174.71 Cr | ₹272.4 Cr | ₹216.9 Cr | ₹193.49 Cr |
| attributable to Owners | ₹172.71 Cr | - | ₹216.45 Cr | ₹193.49 Cr |
| attributable to NCI | ₹0 | - | ₹0 | ₹0 |
| Other Comprehensive Income | -₹6.24 Cr | -₹9.76 Cr | -₹45.12 Lakh | -₹3.45 Cr |
| Total Comprehensive Income | ₹168.47 Cr | ₹262.65 Cr | ₹216.45 Cr | ₹190.04 Cr |
| EBITDA (computed) | ₹378.96 Cr | ₹474.49 Cr | ₹390.94 Cr | ₹344.36 Cr |
| Basic EPS | ₹19.27 | ₹30.06 | ₹23.93 | ₹21.35 |
| Diluted EPS | ₹19.25 | ₹30.04 | ₹23.93 | ₹21.35 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,481.71 Cr | ₹2,906.41 Cr | ₹2,582.1 Cr | ₹2,230.93 Cr |
| Non-current Assets | ₹2,084.41 Cr | ₹1,584.24 Cr | ₹1,236.46 Cr | ₹1,075.17 Cr |
| Current Assets | ₹1,397.29 Cr | ₹1,322.17 Cr | ₹1,345.64 Cr | ₹1,155.76 Cr |
| Property, Plant & Equipment | ₹1,335.92 Cr | ₹1,104.12 Cr | ₹1,014.69 Cr | ₹922.74 Cr |
| Inventories | ₹640.31 Cr | ₹587.58 Cr | ₹642.86 Cr | ₹602.04 Cr |
| Trade Receivables | ₹583.32 Cr | ₹575.4 Cr | ₹519.34 Cr | ₹440.05 Cr |
| Cash & Equivalents | ₹8.53 Cr | ₹6.73 Cr | ₹23.63 Cr | ₹24.93 Cr |
| Equity (Net Worth) | ₹2,124.6 Cr | ₹1,989.91 Cr | ₹1,757.04 Cr | ₹1,558.48 Cr |
| Equity Share Capital | ₹45.33 Cr | ₹45.32 Cr | ₹45.31 Cr | ₹45.31 Cr |
| Borrowings (Non-current) | ₹185.81 Cr | ₹103.56 Cr | ₹3.88 Lakh | ₹18 Lakh |
| Borrowings (Current) | ₹499.82 Cr | ₹292.8 Cr | ₹264.06 Cr | ₹213.78 Cr |
| Total Debt (computed) | ₹685.63 Cr | ₹396.35 Cr | ₹264.1 Cr | ₹213.96 Cr |
| Current Liabilities | ₹937.57 Cr | ₹657.05 Cr | ₹694.38 Cr | ₹591.58 Cr |
| Total Liabilities | ₹1,357.1 Cr | ₹916.5 Cr | ₹825.06 Cr | ₹672.45 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹261.93 Cr | ₹331.56 Cr | ₹216.36 Cr | ₹263 Cr |
| Investing Cash Flow | -₹430.72 Cr | -₹413.9 Cr | -₹214.57 Cr | -₹157.8 Cr |
| Financing Cash Flow | ₹170.58 Cr | ₹65.44 Cr | ₹9.72 Cr | -₹163.47 Cr |
| Capital Expenditure | ₹409.37 Cr | ₹402.04 Cr | ₹155.6 Cr | ₹119.65 Cr |
| Free Cash Flow (computed) | -₹147.44 Cr | -₹70.48 Cr | ₹60.75 Cr | ₹143.35 Cr |
| Dividends Paid | ₹36.26 Cr | ₹31.72 Cr | ₹18.13 Cr | ₹0 |
| Net Change in Cash | ₹1.8 Cr | -₹16.9 Cr | ₹11.51 Cr | -₹58.27 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹582.64 Cr | ₹432.27 Cr | ₹418.33 Cr | ₹386.19 Cr | ₹563.78 Cr | ₹537.78 Cr | ₹458.03 Cr | ₹555.49 Cr | ₹505.77 Cr | ₹448.69 Cr | ₹439.8 Cr | ₹458.36 Cr |
| Other Income | ₹8.05 Cr | -₹37.12 Lakh | ₹5.03 Lakh | ₹1.6 Cr | -₹1.61 Cr | ₹5.03 Cr | ₹4.48 Cr | ₹2.22 Cr | ₹2.03 Cr | ₹1.39 Cr | ₹98 Lakh | ₹48 Lakh |
| Total Income | ₹590.7 Cr | ₹431.9 Cr | ₹418.39 Cr | ₹387.79 Cr | ₹562.17 Cr | ₹542.81 Cr | ₹462.51 Cr | ₹557.71 Cr | ₹507.8 Cr | ₹450.08 Cr | ₹440.78 Cr | ₹458.84 Cr |
| Cost of Materials Consumed | ₹225.76 Cr | ₹209.42 Cr | ₹203.46 Cr | ₹191.42 Cr | ₹185.45 Cr | ₹261.19 Cr | ₹220.58 Cr | ₹219.81 Cr | ₹201.52 Cr | ₹214.96 Cr | ₹221.89 Cr | ₹220.07 Cr |
| Purchases of Stock-in-Trade | ₹8.73 Cr | ₹2.14 Cr | ₹23.26 Cr | ₹21.82 Cr | -₹16.27 Cr | ₹7.87 Cr | ₹98.1 Cr | ₹86.94 Cr | ₹59.91 Cr | ₹38.46 Cr | ₹35.2 Cr | ₹48.65 Cr |
| Changes in Inventories | ₹48.53 Cr | -₹38.9 Cr | -₹16.95 Cr | -₹43.84 Cr | ₹109.57 Cr | ₹6.25 Cr | -₹83.1 Cr | ₹31.5 Cr | -₹8.31 Cr | -₹8.99 Cr | -₹4.84 Cr | ₹2.2 Cr |
| Employee Benefit Expense | ₹45.05 Cr | ₹43.38 Cr | ₹43.41 Cr | ₹41.26 Cr | ₹43.37 Cr | ₹41.63 Cr | ₹37.73 Cr | ₹39.23 Cr | ₹37.4 Cr | ₹36.16 Cr | ₹31.6 Cr | ₹33.25 Cr |
| Finance Costs | ₹16.86 Cr | ₹12.58 Cr | ₹10.67 Cr | ₹6.79 Cr | ₹6.58 Cr | ₹9.97 Cr | ₹5.51 Cr | ₹4.83 Cr | ₹4.68 Cr | ₹4.48 Cr | ₹3.89 Cr | ₹4.17 Cr |
| Depreciation & Amortisation | ₹28.16 Cr | ₹28.62 Cr | ₹24.77 Cr | ₹22.79 Cr | ₹22.82 Cr | ₹23.04 Cr | ₹20.88 Cr | ₹20.17 Cr | ₹19.12 Cr | ₹18.77 Cr | ₹18.14 Cr | ₹17.2 Cr |
| Other Expenses | ₹141.44 Cr | ₹113.93 Cr | ₹90.43 Cr | ₹80.29 Cr | ₹96.03 Cr | ₹92.23 Cr | ₹91.05 Cr | ₹81.56 Cr | ₹97.73 Cr | ₹72.43 Cr | ₹67.95 Cr | ₹69.32 Cr |
| Total Expenses | ₹514.53 Cr | ₹371.16 Cr | ₹379.05 Cr | ₹320.54 Cr | ₹447.55 Cr | ₹442.18 Cr | ₹390.74 Cr | ₹484.03 Cr | ₹412.05 Cr | ₹376.26 Cr | ₹373.83 Cr | ₹394.86 Cr |
| Profit Before Exceptional Items & Tax | ₹76.17 Cr | ₹60.74 Cr | ₹39.33 Cr | ₹67.25 Cr | ₹114.62 Cr | ₹100.63 Cr | ₹71.77 Cr | ₹73.68 Cr | ₹95.75 Cr | ₹73.82 Cr | ₹66.95 Cr | ₹63.98 Cr |
| Exceptional Items | ₹0 | -₹2.79 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹76.17 Cr | ₹57.95 Cr | ₹39.33 Cr | ₹67.25 Cr | ₹114.62 Cr | ₹100.63 Cr | ₹71.77 Cr | ₹73.68 Cr | ₹95.75 Cr | ₹73.82 Cr | ₹66.95 Cr | ₹63.98 Cr |
| Total Tax Expense | ₹20.55 Cr | ₹14.91 Cr | ₹10.77 Cr | ₹15.95 Cr | ₹26.28 Cr | ₹26.64 Cr | ₹17.15 Cr | ₹18.22 Cr | ₹30.5 Cr | ₹21.06 Cr | ₹15.15 Cr | ₹16.89 Cr |
| Net Profit | ₹61.12 Cr | ₹47.96 Cr | ₹27.92 Cr | ₹49.5 Cr | ₹88.34 Cr | ₹73.99 Cr | ₹54.62 Cr | ₹55.45 Cr | ₹65.25 Cr | ₹52.76 Cr | ₹51.8 Cr | ₹47.09 Cr |
| attributable to Owners | ₹61.12 Cr | ₹46.39 Cr | ₹28.57 Cr | - | - | ₹73.99 Cr | ₹54.62 Cr | ₹55.45 Cr | ₹64.36 Cr | ₹52.76 Cr | ₹51.8 Cr | ₹50.97 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹4.87 Cr | -₹1.56 Cr | -₹77.19 Lakh | ₹96.62 Lakh | -₹4.76 Cr | -₹2.71 Cr | -₹2.77 Cr | ₹48.34 Lakh | -₹89.13 Lakh | ₹29.28 Lakh | -₹3.73 Cr | ₹3.88 Cr |
| Total Comprehensive Income | ₹56.25 Cr | ₹46.39 Cr | ₹27.15 Cr | ₹50.47 Cr | ₹83.58 Cr | ₹71.28 Cr | ₹51.85 Cr | ₹55.94 Cr | ₹64.36 Cr | ₹53.06 Cr | ₹48.07 Cr | ₹50.97 Cr |
| EBITDA (computed) | ₹121.18 Cr | ₹101.94 Cr | ₹74.77 Cr | ₹96.84 Cr | ₹144.02 Cr | ₹133.64 Cr | ₹98.16 Cr | ₹98.68 Cr | ₹119.55 Cr | ₹97.07 Cr | ₹88.98 Cr | ₹85.35 Cr |
| Basic EPS | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.46 | ₹9.75 | ₹8.16 | ₹6.03 | ₹6.12 | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 |
| Diluted EPS | ₹6.74 | ₹5.29 | ₹3.08 | ₹5.46 | ₹9.74 | ₹8.16 | ₹6.02 | ₹6.12 | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹1,797.55 Cr | ₹1,771.35 Cr | ₹1,502.13 Cr | ₹1,511.25 Cr |
| Other Income | ₹15.32 Cr | ₹14.49 Cr | ₹11.01 Cr | ₹1.28 Cr |
| Total Income | ₹1,812.87 Cr | ₹1,785.84 Cr | ₹1,513.14 Cr | ₹1,512.53 Cr |
| Cost of Materials Consumed | ₹834.53 Cr | ₹803.98 Cr | ₹761.57 Cr | ₹899.45 Cr |
| Purchases of Stock-in-Trade | ₹49.19 Cr | ₹27.43 Cr | ₹13.76 Cr | ₹9.7 Cr |
| Changes in Inventories | -₹62.58 Cr | ₹47.85 Cr | -₹23.36 Cr | -₹91.22 Cr |
| Employee Benefit Expense | ₹170.48 Cr | ₹152.88 Cr | ₹130.33 Cr | ₹122.16 Cr |
| Finance Costs | ₹46.9 Cr | ₹25.63 Cr | ₹16.63 Cr | ₹20.48 Cr |
| Depreciation & Amortisation | ₹104.3 Cr | ₹79.06 Cr | ₹66.01 Cr | ₹55.77 Cr |
| Other Expenses | ₹433.02 Cr | ₹312.66 Cr | ₹273.67 Cr | ₹262.83 Cr |
| Total Expenses | ₹1,575.84 Cr | ₹1,449.5 Cr | ₹1,238.62 Cr | ₹1,279.17 Cr |
| Profit Before Exceptional Items & Tax | ₹237.03 Cr | ₹336.34 Cr | ₹274.52 Cr | ₹233.36 Cr |
| Exceptional Items | -₹2.79 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹234.24 Cr | ₹336.34 Cr | ₹274.52 Cr | ₹233.36 Cr |
| Total Tax Expense | ₹58.04 Cr | ₹78.99 Cr | ₹73.87 Cr | ₹61.63 Cr |
| Net Profit | ₹176.2 Cr | ₹257.35 Cr | ₹200.65 Cr | ₹171.73 Cr |
| Other Comprehensive Income | -₹3.95 Cr | -₹5.16 Cr | ₹13.31 Lakh | -₹70 Lakh |
| Total Comprehensive Income | ₹172.25 Cr | ₹252.19 Cr | ₹200.78 Cr | ₹171.03 Cr |
| EBITDA (computed) | ₹388.23 Cr | ₹441.03 Cr | ₹357.17 Cr | ₹309.61 Cr |
| Basic EPS | ₹19.44 | ₹28.39 | ₹22.14 | ₹18.95 |
| Diluted EPS | ₹19.42 | ₹28.38 | ₹22.14 | ₹18.85 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,327.76 Cr | ₹2,723.61 Cr | ₹2,296.91 Cr | ₹1,963.27 Cr |
| Non-current Assets | ₹1,934.33 Cr | ₹1,510.81 Cr | ₹1,162.85 Cr | ₹1,004.3 Cr |
| Current Assets | ₹1,393.43 Cr | ₹1,212.8 Cr | ₹1,134.06 Cr | ₹958.97 Cr |
| Property, Plant & Equipment | ₹1,335.92 Cr | ₹1,028.77 Cr | ₹936.47 Cr | ₹847.08 Cr |
| Inventories | ₹636.21 Cr | ₹544.22 Cr | ₹582.15 Cr | ₹537.68 Cr |
| Trade Receivables | ₹586.55 Cr | ₹552.59 Cr | ₹448.82 Cr | ₹361.61 Cr |
| Cash & Equivalents | ₹5.54 Cr | ₹2.84 Cr | ₹4 Cr | ₹13.11 Cr |
| Equity (Net Worth) | ₹1,982.35 Cr | ₹1,843.87 Cr | ₹1,621.46 Cr | ₹1,438.58 Cr |
| Equity Share Capital | ₹45.33 Cr | ₹45.32 Cr | ₹45.31 Cr | ₹45.31 Cr |
| Borrowings (Non-current) | ₹185.81 Cr | ₹103.56 Cr | ₹0 | ₹0 |
| Borrowings (Current) | ₹499.82 Cr | ₹291.3 Cr | ₹250.8 Cr | ₹206.71 Cr |
| Total Debt (computed) | ₹685.63 Cr | ₹394.86 Cr | ₹250.8 Cr | ₹206.71 Cr |
| Current Liabilities | ₹925.88 Cr | ₹622.33 Cr | ₹555.58 Cr | ₹455.31 Cr |
| Total Liabilities | ₹1,345.41 Cr | ₹879.74 Cr | ₹675.45 Cr | ₹524.69 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | ₹256.13 Cr | ₹340.01 Cr | ₹183.7 Cr | ₹228.69 Cr |
| Investing Cash Flow | -₹424.02 Cr | -₹419.8 Cr | -₹184.4 Cr | -₹115.56 Cr |
| Financing Cash Flow | ₹170.58 Cr | ₹78.63 Cr | ₹4.4 Cr | -₹156.52 Cr |
| Capital Expenditure | ₹409.37 Cr | ₹391.48 Cr | ₹145.96 Cr | ₹0 |
| Free Cash Flow (computed) | -₹153.23 Cr | -₹51.47 Cr | ₹37.74 Cr | ₹228.69 Cr |
| Dividends Paid | ₹36.26 Cr | ₹31.72 Cr | ₹18.13 Cr | ₹18.12 Cr |
| Net Change in Cash | ₹2.7 Cr | -₹1.16 Cr | ₹3.7 Cr | -₹43.39 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹579.7 Cr | ₹425.25 Cr | ₹417.29 Cr | ₹375.31 Cr | ₹529.62 Cr | ₹470.95 Cr | ₹377.29 Cr | ₹393.49 Cr | ₹414.82 Cr | ₹373.03 Cr | ₹356.14 Cr | ₹358.14 Cr |
| Other Income | ₹10.53 Cr | -₹37.12 Lakh | ₹3.15 Cr | ₹1.6 Cr | -₹2.51 Cr | ₹11.94 Cr | ₹2.95 Cr | ₹2.11 Cr | ₹5.69 Cr | ₹19.94 Lakh | ₹0 | ₹4.86 Cr |
| Total Income | ₹590.23 Cr | ₹424.88 Cr | ₹420.44 Cr | ₹376.91 Cr | ₹527.12 Cr | ₹482.88 Cr | ₹380.24 Cr | ₹395.6 Cr | ₹420.5 Cr | ₹373.23 Cr | ₹356.14 Cr | ₹363 Cr |
| Cost of Materials Consumed | ₹227.38 Cr | ₹209.85 Cr | ₹204.45 Cr | ₹192.85 Cr | ₹173.29 Cr | ₹242.91 Cr | ₹196.38 Cr | ₹191.41 Cr | ₹179.69 Cr | ₹191.11 Cr | ₹196.88 Cr | ₹193.64 Cr |
| Purchases of Stock-in-Trade | ₹7.07 Cr | ₹1.86 Cr | ₹20.41 Cr | ₹19.85 Cr | ₹3.34 Cr | ₹2.44 Cr | ₹20 Cr | ₹1.65 Cr | ₹0 | ₹0 | ₹0 | ₹14.01 Cr |
| Changes in Inventories | ₹45.5 Cr | -₹40.28 Cr | -₹14.86 Cr | -₹52.95 Cr | ₹83.47 Cr | -₹9.15 Cr | -₹36.56 Cr | ₹10.09 Cr | ₹7.36 Cr | -₹5.32 Cr | -₹6.11 Cr | -₹19.29 Cr |
| Employee Benefit Expense | ₹43.73 Cr | ₹42.62 Cr | ₹43.12 Cr | ₹41.01 Cr | ₹41.38 Cr | ₹39.02 Cr | ₹35.47 Cr | ₹37.01 Cr | ₹34.67 Cr | ₹34.29 Cr | ₹29.84 Cr | ₹31.53 Cr |
| Finance Costs | ₹16.86 Cr | ₹12.58 Cr | ₹10.66 Cr | ₹6.79 Cr | ₹6.29 Cr | ₹9.7 Cr | ₹5.39 Cr | ₹4.25 Cr | ₹4.42 Cr | ₹4.1 Cr | ₹3.82 Cr | ₹4.03 Cr |
| Depreciation & Amortisation | ₹28.16 Cr | ₹28.62 Cr | ₹24.77 Cr | ₹22.76 Cr | ₹20.83 Cr | ₹21.04 Cr | ₹18.89 Cr | ₹18.29 Cr | ₹17.32 Cr | ₹16.94 Cr | ₹16.32 Cr | ₹15.44 Cr |
| Other Expenses | ₹138.94 Cr | ₹108.25 Cr | ₹90.19 Cr | ₹79.41 Cr | ₹85.02 Cr | ₹80.75 Cr | ₹77.23 Cr | ₹69.67 Cr | ₹85.75 Cr | ₹64.68 Cr | ₹61.73 Cr | ₹61.51 Cr |
| Total Expenses | ₹507.65 Cr | ₹363.51 Cr | ₹378.74 Cr | ₹309.73 Cr | ₹413.62 Cr | ₹386.7 Cr | ₹316.81 Cr | ₹332.37 Cr | ₹329.22 Cr | ₹305.79 Cr | ₹302.48 Cr | ₹300.87 Cr |
| Profit Before Exceptional Items & Tax | ₹82.59 Cr | ₹61.38 Cr | ₹41.7 Cr | ₹67.17 Cr | ₹113.5 Cr | ₹96.18 Cr | ₹63.43 Cr | ₹63.23 Cr | ₹91.28 Cr | ₹67.44 Cr | ₹53.66 Cr | ₹62.13 Cr |
| Exceptional Items | ₹0 | -₹2.79 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹82.59 Cr | ₹58.58 Cr | ₹41.7 Cr | ₹67.17 Cr | ₹113.5 Cr | ₹96.18 Cr | ₹63.43 Cr | ₹63.23 Cr | ₹91.28 Cr | ₹67.44 Cr | ₹53.66 Cr | ₹62.13 Cr |
| Total Tax Expense | ₹20.55 Cr | ₹14.74 Cr | ₹10.77 Cr | ₹15.95 Cr | ₹24.66 Cr | ₹22.66 Cr | ₹15.6 Cr | ₹16.08 Cr | ₹28.26 Cr | ₹19.25 Cr | ₹11.86 Cr | ₹14.5 Cr |
| Net Profit | ₹62.03 Cr | ₹43.84 Cr | ₹30.93 Cr | ₹51.22 Cr | ₹88.85 Cr | ₹73.52 Cr | ₹47.84 Cr | ₹47.14 Cr | ₹63.02 Cr | ₹48.19 Cr | ₹41.18 Cr | ₹47.63 Cr |
| Other Comprehensive Income | -₹3.52 Cr | ₹63.01 Lakh | -₹2.12 Cr | ₹1.05 Cr | -₹1.88 Cr | -₹1.87 Cr | -₹1.17 Cr | -₹23.16 Lakh | -₹1.11 Cr | ₹70.39 Lakh | ₹0 | ₹1.17 Cr |
| Total Comprehensive Income | ₹58.51 Cr | ₹44.47 Cr | ₹28.81 Cr | ₹52.27 Cr | ₹86.97 Cr | ₹71.65 Cr | ₹46.66 Cr | ₹46.91 Cr | ₹61.91 Cr | ₹48.89 Cr | ₹41.18 Cr | ₹48.8 Cr |
| EBITDA (computed) | ₹127.6 Cr | ₹102.57 Cr | ₹77.13 Cr | ₹96.73 Cr | ₹140.62 Cr | ₹126.93 Cr | ₹87.72 Cr | ₹85.77 Cr | ₹113.03 Cr | ₹88.47 Cr | ₹73.8 Cr | ₹81.6 Cr |
| Basic EPS | ₹6.84 | ₹4.84 | ₹3.41 | ₹5.65 | ₹9.80 | ₹8.11 | ₹5.28 | ₹5.20 | ₹6.95 | ₹5.32 | ₹4.61 | ₹5.26 |
| Diluted EPS | ₹6.84 | ₹4.83 | ₹3.41 | ₹5.65 | ₹9.80 | ₹8.11 | ₹5.27 | ₹5.20 | ₹6.95 | ₹5.32 | ₹4.61 | ₹5.26 |
Board & Governance of Aarti Pharmalabs Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Aarti Pharmalabs Limited has 12 directors - 6 independent and 2 executive. The board is chaired by Rashesh Chandrakant Gogri.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Rashesh Chandrakant Gogri | Non-Executive - Non Independent Director · Chairperson | 2021-08-07 | 3 |
| Hetal Gogri Gala | Executive Director · MD | 2021-08-07 | 2 |
| Narendra Jagannath Salvi | Executive Director · MD | 2021-08-07 | 2 |
| Rajendra Vallabhaji Gogri | Non-Executive - Non Independent Director | 2021-08-07 | 4 |
| Parimal Hasmukhlal Desai | Non-Executive - Non Independent Director | 2022-10-17 | 3 |
| Vinay Gopal Nayak | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Bhavesh Rasiklal Vora | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Jeenal Kenil Savla | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Rupal Anand Vora | Non-Executive - Independent Director | 2022-10-17 | 6 |
| Vilas Gajanan Gaikar | Non-Executive - Independent Director | 2022-10-17 | 1 |
| Pradeep Hari Thakur | Non-Executive - Independent Director | 2024-05-13 | 3 |
| Nehal Garewal | Non-Executive - Non Independent Director | 2024-05-13 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Bhavesh Rasiklal Vora (Chairperson), Vinay Gopal Nayak, Vilas Gajanan Gaikar, Jeenal Kenil Savla, Hetal Gogri Gala, Narendra Jagannath Salvi |
| Nomination and remuneration committee | Jeenal Kenil Savla (Chairperson), Vinay Gopal Nayak, Rashesh Chandrakant Gogri |
| Stakeholders Relationship Committee | Rajendra Vallabhaji Gogri (Chairperson), Narendra Jagannath Salvi, Bhavesh Rasiklal Vora, Rupal Anand Vora |
| Risk Management Committee | Rashesh Chandrakant Gogri (Chairperson), Hetal Gogri Gala, Narendra Jagannath Salvi, Rajendra Vallabhaji Gogri, Parimal Hasmukhlal Desai, Vinay Gopal Nayak |
| Corporate Social Responsibility Committee | Hetal Gogri Gala (Chairperson), Rajendra Vallabhaji Gogri, Jeenal Kenil Savla, Vilas Gajanan Gaikar |
| Finance and Investment Committee | Rashesh Chandrakant Gogri (Chairperson), Hetal Gogri Gala, Narendra Jagannath Salvi, Rajendra Vallabhaji Gogri, Parimal Hasmukhlal Desai |
Charges & Borrowings of Aarti Pharmalabs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2026 | Others | ₹125 Cr | Open |
| 29 Jan 2026 | Others | ₹106 Cr | Open |
| 17 Mar 2025 | Idbi Bank Limited | ₹75 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹70 Cr | Open |
| 08 Sep 2024 | Citi Bank N.A. | ₹30 Cr | Open |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Aarti Pharmalabs Limited
View historical data on people associated with Aarti Pharmalabs Limited, including employment history and EPFO contributions.
Employee and EPFO history for Aarti Pharmalabs Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aarti Pharmalabs Limited
GST registrations and filing compliance for Aarti Pharmalabs Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aarti Pharmalabs Limited
Credit ratings, litigation, and regulatory alerts for Aarti Pharmalabs Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aarti Pharmalabs Limited
MSME payment history for Aarti Pharmalabs Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aarti Pharmalabs Limited
Corporate group structure for Aarti Pharmalabs Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aarti Pharmalabs Limited
MCA filings and documents for Aarti Pharmalabs Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aarti Pharmalabs Limited
Recent News on Aarti Pharmalabs Limited
Frequently Asked Questions about Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is an active public limited company in the pharma sector based in Vapi, Gujarat, India. It was incorporated on 22 November 2019 (7+ years old) and is registered under CIN L24100GJ2019PLC110964. Listed on BSE: 543748. The company has 2,004 employees.
Aarti Pharmalabs Limited reported revenue of ₹1,819.44 Cr for FY 2026 (down 13.98% YoY) based on consolidated NSE filings.
The current directors of Aarti Pharmalabs Limited are:
- Vilas Gaikar Gajanan - Director
- Rupal Anand Vora - Director
- Parimal Hasmukhlal Desai - Director
- Hetal Gogri Gala - Managing Director
- Bhavesh Rasiklal Vora - Director
- Vinay Gopal Nayak - Director
- Rajendra Vallabhaji Gogri - Director
- Rashesh Chandrakant Gogri - Director
- Narendra Jagannath Salvi - Managing Director
- Jeenal Kenil Savla - Director
- Pradeep Hari Thakur - Director
- Nehal Garewal - Director
The primary industry of Aarti Pharmalabs Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Aarti Pharmalabs Limited is listed on BSE with code 543748.
Aarti Pharmalabs Limited can be reached at the registered office: Plot No. 22C1 & 22C2 1St Phase G.I.D.C. Vapi, Gujarat, India – 396195, or through the website aartipharmalabs.com.